The minus of a plus is a minus. Mass death of selected neuron populations in sporadic late-onset neurodegenerative disease may be due to a combination of subtly decreased capacity to repair oxidative DNA damage and increased propensity for damage-related apoptosis

References

• Dorsey ER, Constantinescu R, Thompson JP, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007;68:384–386.
   PubMed Web of Science ®Google Scholar
• Hebert LE, Weuve J, Scherr PA, et al. Alzheimer disease in the United States (2010–2050) estimated using the 2010 Census. Neurology. 2013;80:1778–1783.
   PubMed Web of Science ®Google Scholar
• Ferri CP, Prince M, Brayne C, et al. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366:2112–2117.
   PubMed Web of Science ®Google Scholar
• von Campenhausen S, Bornschein B, Wick R, et al. Prevalence and incidence of Parkinson's disease in Europe. Eur Neuropsychopharmacol. 2005;15:473–490.
   PubMed Web of Science ®Google Scholar
• Van Den Eeden SK, Tanner CM, Bernstein AL, et al. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol. 2003;157:1015–1022.
   PubMed Web of Science ®Google Scholar
• Gusella JF, MacDonald ME. Huntington's disease: the case for genetic modifiers. Genome Med [Internet]. 2009 [cited 2016 Jan 15];1:80. Available from: http://dx.doi.org/10.1186/gm80.
   PubMed Web of Science ®Google Scholar
• Zinman L, Liu HN, Sato C, et al. A mechanism for low penetrance in an ALS family with a novel SOD1 deletion. Neurology. 2009;72:1153–1159.
   PubMed Web of Science ®Google Scholar
• Almkvist O, Axelman K, Basun H, et al. Clinical findings in nondemented mutation carriers predisposed to Alzheimer's disease: a model of mild cognitive impairment. Acta Neurol Scand Suppl. 2003;179:77–82.
   PubMedGoogle Scholar
• Aasly JO, Shi M, Sossi V, et al. Cerebrospinal fluid amyloid beta and tau in LRRK2 mutation carriers. Neurology. 2012;78:55–61.
   PubMed Web of Science ®Google Scholar
• Snowdon DA, Greiner LH, Mortimer JA, et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA. 1997;277:813–817.
   PubMed Web of Science ®Google Scholar
• Gupta A, Iadecola C. Impaired Aβ clearance: a potential link between atherosclerosis and Alzheimer's disease. Front Aging Neurosci [Internet]. 2015 [ cited];7:115. Available from: http://dx.doi.org/10.3389/fnagi.2015.00115.
   PubMed Web of Science ®Google Scholar
• Giannakopoulos P, Hof PR, Mottier S, et al. Neuropathological changes in the cerebral cortex of 1258 cases from a geriatric hospital: retrospective clinicopathological evaluation of a 10-year autopsy population. Acta Neuropathol. 1994;87:456–468.
   PubMed Web of Science ®Google Scholar
• Nelson PT, Braak H, Markesbery WR. Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship. J Neuropathol Exp Neurol. 2009;68:1–14.
   PubMed Web of Science ®Google Scholar
• Cowan WM. Neuronal death as a regulative mechanism in the control of cell number in the nervous system. In: Rockstein M, editor. Development and aging in the nervous system. New York (NY): Academic Press; 1973. p. 19–41.
   Google Scholar
• Leuba G, Garey LJ. Evolution of neuronal numerical density in the developing and aging human visual cortex. Hum Neurobiol. 1987;6:11–18.
   PubMedGoogle Scholar
• Raveh-Amit H, Berzsenyi S, Vas V, et al. Tissue resident stem cells: till death do us part. Biogerontology. 2013;14:573–590.
   PubMed Web of Science ®Google Scholar
• Chakarov S, Petkova R, Pankov R. Stvolovi kletki [Stem cells]. 2nd ed. Sofia: Prof. Marin Drinov Academic Publishing House; 2014. Chapter 2, Biologia na stvolovite kletki [Stem cell biology]; p. 39–140. Bulgarian.
   Google Scholar
• Abitz M, Nielsen RD, Jones EG, et al. Excess of neurons in the human newborn mediodorsal thalamus compared with that of the adult. Cereb Cortex. 2007;17:2573–2578.
   PubMed Web of Science ®Google Scholar
• Kuhn HG, Dickinson-Anson H, Gage FH. Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J Neurosci. 1996;16:2027–2033.
   PubMed Web of Science ®Google Scholar
• Simić G, Kostović; I, Winblad B, et al. Volume and number of neurons of the human hippocampal formation in normal aging and Alzheimer's disease. J Comp Neurol. 1997;379:482–494.
   PubMed Web of Science ®Google Scholar
• West MJ, Kawas CH, Stewart WF, et al. Hippocampal neurons in pre-clinical Alzheimer's disease. Neurobiol Aging. 2004;25:1205–1212.
   PubMed Web of Science ®Google Scholar
• Eckenhoff MF, Rakic P. Nature and fate of proliferative cells in the hippocampal dentate gyrus during the life span of the rhesus monkey. J Neurosci. 1988;8:2729–2747.
   PubMed Web of Science ®Google Scholar
• Doetsch F, Caille I, Lim DA, et al. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell. 1999;97:703–716.
   PubMed Web of Science ®Google Scholar
• Cameron HA, McKay RD. Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus. J Comp Neurol. 2001;435:406–417.
   PubMed Web of Science ®Google Scholar
• Bedard A, Parent A. Evidence of newly generated neurons in the human olfactory bulb. Brain Res Dev Brain Res. 2004;151:159–168.
   PubMedGoogle Scholar
• Ponti G, Peretto B, Bonfanti L. Genesis of neuronal and glial progenitors in the cerebellar cortex of peripuberal and adult rabbits. PLoS One [Internet]. 2008 [cited 2016 Jan 15];3:e2366. Available from: http://dx.doi.org/10.1371/journal.pone.0002366.
   PubMed Web of Science ®Google Scholar
• Larsen CC, Bonde Larsen K, Bogdanovic N, et al. Total number of cells in the human newborn telencephalic wall. Neuroscience. 2006;139:999–1003.
   PubMed Web of Science ®Google Scholar
• Doetsch F. The glial identity of neural stem cells. Nat Neurosci. 2003;6:1127–1134.
   PubMed Web of Science ®Google Scholar
• Uchida N, Buck DW, He D, et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A. 2000;97:14720–14725.
   PubMed Web of Science ®Google Scholar
• Bracko O, Singer T, Aigner S, et al. Gene expression profiling of neural stem cells and their neuronal progeny reveals IGF2 as a regulator of adult hippocampal neurogenesis. J Neurosci. 2012;32:3376–3387.
   PubMed Web of Science ®Google Scholar
• Macas J, Nern C, Plate KH, et al. Increased generation of neuronal progenitors after ischemic injury in the aged adult human forebrain. J Neurosci. 2006;26:13114–13119.
   PubMed Web of Science ®Google Scholar
• Zhao M, Momma S, Delfani K, et al. Evidence for neurogenesis in the adult mammalian substantia nigra. Proc Natl Acad Sci U S A. 2003;100:7925–7930.
   PubMed Web of Science ®Google Scholar
• Shan X, Chi L, Bishop M, et al. Enhanced de novo neurogenesis and dopaminergic neurogenesis in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease-like mice. Stem Cells. 2006;24:1280–1287.
   PubMed Web of Science ®Google Scholar
• Chi L, Ke Y, Luo C, et al. Motor neuron degeneration promotes neural progenitor cell proliferation, migration, and neurogenesis in the spinal cords of amyotrophic lateral sclerosis mice. Stem Cells. 2006;24:34–43.
   PubMed Web of Science ®Google Scholar
• Yu Y, He J, Zhang Y, et al. Increased hippocampal neurogenesis in the progressive stage of Alzheimer's disease phenotype in an APP/PS1 double transgenic mouse model. Hippocampus. 2009;19:1247–1253.
   PubMed Web of Science ®Google Scholar
• Rodríguez JJ, Jones VC, Verkhratsky A. Impaired cell proliferation in the subventricular zone in an Alzheimer's disease model. Neuroreport. 2009;20:907–912.
   PubMed Web of Science ®Google Scholar
• Demars M, Hu YS, Gadadhar A, et al. Impaired neurogenesis is an early event in the etiology of familial Alzheimer's disease in transgenic mice. J Neurosci Res. 2010;88:2103–2117.
   PubMed Web of Science ®Google Scholar
• Jin K, Peel AL, Mao XO, et al. Increased hippocampal neurogenesis in Alzheimer's disease. Proc Natl Acad Sci U S A. 2004;101:343–347.
   PubMed Web of Science ®Google Scholar
• Zekanowski C, Wojda U. Aneuploidy, chromosomal missegregation, and cell cycle reentry in Alzheimer's disease. Acta Neurobiol Exp (Wars). 2009;69:232–253.
   PubMed Web of Science ®Google Scholar
• Duff K, McCaffrey RJ, Solomon GS. The Pocket Smell Test: successfully discriminating probable Alzheimer's dementia from vascular dementia and major depression. J Neuropsychiatry Clin Neurosci. 2002;14:197–201.
   PubMed Web of Science ®Google Scholar
• Pardini M, Huey ED, Cavanagh AL, et al. Olfactory function in corticobasal syndrome and frontotemporal dementia. Arch Neurol. 2009;66:92–96.
   PubMed Web of Science ®Google Scholar
• Doty RL. Olfactory dysfunction in Parkinson disease. Nat Rev Neurol. 2012;8:329–339.
   PubMed Web of Science ®Google Scholar
• Ohm TG, Braak H. Olfactory bulb changes in Alzheimer's disease. Acta Neuropathol. 1987;73:365–369.
   PubMed Web of Science ®Google Scholar
• Chen S, Tan HY, Wu ZH, et al. Imaging of olfactory bulb and gray matter volumes in brain areas associated with olfactory function in patients with Parkinson's disease and multiple system atrophy. Eur J Radiol. 2014;83:564–570.
   PubMed Web of Science ®Google Scholar
• Yang Y, Geldmacher DS, Herrup K. DNA replication precedes neuronal cell death in Alzheimer's disease. J Neurosci. 2001;21:2661–2668.
   PubMed Web of Science ®Google Scholar
• Jordan-Sciutto KL, Dorsey R, Chalovich EM, et al. Expression patterns of retinoblastoma protein in Parkinson disease. J Neuropathol Exp Neurol. 2003;62:68–74.
   PubMed Web of Science ®Google Scholar
• Ranganathan S, Bowser R. Alterations in G(1) to S phase cell-cycle regulators during amyotrophic lateral sclerosis. Am J Pathol. 2003;162:823–835.
   PubMed Web of Science ®Google Scholar
• Lopes JP, Oliveira CR, Agostinho P. Cell cycle re-entry in Alzheimer's disease: a major neuropathological characteristic? Curr Alzheimer Res. 2009;6:205–212.
   PubMed Web of Science ®Google Scholar
• Hradek AC, Lee HP, Siedlak SL, et al. Distinct chronology of neuronal cell cycle re-entry and tau pathology in the 3xTg-AD mouse model and Alzheimer's disease patients. J Alzheimers Dis. 2015;43:57–65.
   PubMed Web of Science ®Google Scholar
• Silva AR, Santos AC, Farfel JM, et al. Repair of oxidative DNA damage, cell-cycle regulation and neuronal death may influence the clinical manifestation of Alzheimer's disease. PLoS One [Internet]. 2014 [cited 2016 Jan 15];9:e99897. Available from: http://dx.doi.org/10.1371/journal.pone.0099897
   PubMed Web of Science ®Google Scholar
• Ishihara Y, Itoh K, Mitsuda Y, et al. Involvement of brain oxidation in the cognitive impairment in a triple transgenic mouse model of Alzheimer's disease: noninvasive measurement of the brain redox state by magnetic resonance imaging. Free Radic Res. 2013;47:731–739.
   PubMed Web of Science ®Google Scholar
• Matsumura A, Emoto MC, Suzuki S, et al. Evaluation of oxidative stress in the brain of a transgenic mouse model of Alzheimer disease by in vivo electron paramagnetic resonance imaging. Free Radic Biol Med. 2015;85:165–173.
   PubMed Web of Science ®Google Scholar
• Mecocci P, MacGarvey U, Beal MF. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol. 1994;36:747–751.
   PubMed Web of Science ®Google Scholar
• Wang J, Xiong S, Xie C, et al. Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease. J Neurochem. 2005;93:953–962.
   PubMed Web of Science ®Google Scholar
• Necchi D, Pinto A, Tillhon M, et al. Defective DNA repair and increased chromatin binding of DNA repair factors in Down syndrome fibroblasts. Mutat Res. 2015;780:15–23.
   PubMed Web of Science ®Google Scholar
• Yamaguchi H, Kajitani K, Dan Y, et al. MTH1, an oxidized purine nucleoside triphosphatase, protects the dopamine neurons from oxidative damage in nucleic acids caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Cell Death Differ. 2006;13:551–563.
   PubMed Web of Science ®Google Scholar
• Nakabeppu Y, Tsuchimoto D, Yamaguchi H, et al. Oxidative damage in nucleic acids and Parkinson's disease. J Neurosci Res. 2007;85:919–934.
   PubMed Web of Science ®Google Scholar
• Cardozo-Pelaez F, Sanchez-Contreras M, Nevin AB. Ogg1 null mice exhibit age-associated loss of the nigrostriatal pathway and increased sensitivity to MPTP. Neurochem Int. 2012;61:721–730.
   PubMed Web of Science ®Google Scholar
• Kovtun IV, Liu Y, Bjoras M, et al. OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells. Nature. 2007;447:447–452.
   PubMed Web of Science ®Google Scholar
• Alam ZI, Jenner A, Daniel SE, et al. Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J Neurochem. 1997;69:1196–1203.
   PubMed Web of Science ®Google Scholar
• Shimura-Miura H, Hattori N, Kang D, et al. Increased 8-oxo-dGTPase in the mitochondria of substantia nigral neurons in Parkinson's disease. Ann Neurol. 1999;46:920–924.
   PubMed Web of Science ®Google Scholar
• Fukae J, Takanashi M, Kubo S, et al. Expression of 8-oxoguanine DNA glycosylase (OGG1) in Parkinson's disease and related neurodegenerative disorders. Acta Neuropathol. 2005;109:256–262.
   PubMed Web of Science ®Google Scholar
• Arai T, Fukae J, Hatano T, et al. Up-regulation of hMUTYH, a DNA repair enzyme, in the mitochondria of substantia nigra in Parkinson's disease.Acta Neuropathol. 2006;112:139–145.
   PubMed Web of Science ®Google Scholar
• Chehab NH, Malikzay A, Appel M, et al. Chk2/hCds1 functions as a DNA damage checkpoint in G-1 by stabilising p53. Genes Dev. 2000;14:278–288.
   PubMed Web of Science ®Google Scholar
• Paull TT, Rogakou EP, Yamazaki V, et al. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol. 2000;10:886–895.
   PubMed Web of Science ®Google Scholar
• Younes-Mhenni S, Frih-Ayed M, Kerkeni A, et al. Peripheral blood markers of oxidative stress in Parkinson's disease. Eur Neurol. 2007;58:78–83.
   PubMed Web of Science ®Google Scholar
• Zivković L, Spremo-Potparević; B, Siedlak SL, et al. DNA damage in Alzheimer disease lymphocytes and its relation to premature centromere division. Neurodegener Dis. 2013;12:156–163.
   PubMed Web of Science ®Google Scholar
• Mellon I, Bhor VA, Hanawalt PC. Preferential repair of an active gene in human cells. Proc Natl Acad Sci U S A. 1986;83:8878–8882.
   PubMed Web of Science ®Google Scholar
• Hu W, Feng Z, Chasin LA, et al. Transcription-coupled and transcription-independent repair of cyclobutane pyrimidine dimers in the dihydrofolate reductase gene. J Biol Chem. 2002;277:38305–38310.
   PubMed Web of Science ®Google Scholar
• Niida H, Nakanishi M. DNA damage checkpoints in mammals. Mutagenesis. 2006;21:3–9.
   PubMed Web of Science ®Google Scholar
• Nouspikel T, Hanawalt PC. DNA repair in terminally differentiated cells. DNA Repair (Amst). 2002;1:59–75.
   PubMed Web of Science ®Google Scholar
• Nouspikel T. DNA repair in mammalian cells: Nucleotide excision repair: variations on versatility. Cell Mol Life Sci. 2009;66:994–1009.
   PubMed Web of Science ®Google Scholar
• Nouspikel TP, Hyka-Nouspikel N, Hanawalt PC. Transcription domain-associated repair in human cells. Mol Cell Biol. 2006;6:8722–8730.
   Web of Science ®Google Scholar
• Hyka-Nouspikel N, Lemonidis K, Lu WT, et al. Circulating human B lymphocytes are deficient in nucleotide excision repair and accumulate mutations upon proliferation. Blood. 2011;117,6277–86.
   PubMed Web of Science ®Google Scholar
• Bauer M, Goldstein M, Christmann M, et al. Human monocytes are severely impaired in base and DNA double-strand break repair that renders them vulnerable to oxidative stress. Proc Natl Acad Sci U S A. 2011;108:21105–21110.
   PubMed Web of Science ®Google Scholar
• Bauer M, Goldstein M, Heylmann D, et al. Human monocytes undergo excessive apoptosis following temozolomide activating the ATM/ATR pathway while dendritic cells and macrophages are resistant. PLoS One. 2012;7:e39956.
   PubMed Web of Science ®Google Scholar
• Valledor AF, Comalada M, Santamaría-Babi LF, et al. Macrophage proinflammatory activation and deactivation: a question of balance. Adv Immunol. 2010;108:1–20.
   PubMed Web of Science ®Google Scholar
• Lindahl T. Instability and decay of the primary structure of DNA. Nature. 1993;362:709–715.
   PubMed Web of Science ®Google Scholar
• Akomolafe A, Beiser A, Meigs JB, et al. Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study. Arch Neurol. 2006;63:1551–1555.
   PubMed Web of Science ®Google Scholar
• Pasquier F, Boulogne A, Leys D, et al. Diabetes mellitus and dementia. Diabetes Metab. 2006;32:403–414.
   PubMed Web of Science ®Google Scholar
• Chen J, Li S, Sun W, Li J. Anti-diabetes drug pioglitazone ameliorates synaptic defects in AD transgenic mice by inhibiting cyclin-dependent kinase5 activity. PLoS One [Internet]. 2015 [cited 2016 Jan 15];10:e0123864. Available from: http://dx.doi.org/10.1371/journal.pone.0123864
   Google Scholar
• Raber J, Huang Y, Ashford JW. ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol Aging. 2004;25:641–650.
   PubMed Web of Science ®Google Scholar
• Seidl R, Bidmon B, Bajo M, et al. Evidence for apoptosis in the fetal Down syndrome brain. J Child Neurol. 2001;16:438–442.
   PubMed Web of Science ®Google Scholar
• Seidl R, Fang-Kircher S, Bidmon B, et al. Apoptosis-associated proteins p53 and APO-1/Fas (CD95) in brains of adult patients with Down syndrome. Neurosci Lett. 1999;260:9–12.
   PubMed Web of Science ®Google Scholar
• Chihara T, Kitabayashi A, Morimoto M, et al. Caspase inhibition in select olfactory neurons restores innate attraction behavior in aged Drosophila. PLoS Genet [Internet]. 2014 [cited 2016 Jan 15];10:e1004437. Available from: http://dx.doi.org/10.1371/journal.pgen.1004437.
   Google Scholar
• Beal MF. Mechanisms of excitotoxicity in neurologic diseases. FASEB J. 1992;6:3338–3344.
   PubMed Web of Science ®Google Scholar
• Palmer GC. Neuroprotection by NMDA receptor antagonists in a variety of neuropathologies. Curr Drug Targ. 2001;2:241–271.
   PubMed Web of Science ®Google Scholar
• Ikonomidou C, Turski L. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol. 2002;1:383–386.
   PubMed Web of Science ®Google Scholar
• Tovar KR, Westbrook GL, The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro. J Neurosci. 1999;19:4180–4188.
   PubMed Web of Science ®Google Scholar
• Harris AZ, Pettit DL. Extrasynaptic and synaptic NMDA receptors form stable and uniform pools in rat hippocampal slices. J Physiol. 2007;584:509–519.
   PubMed Web of Science ®Google Scholar
• Goula AV, Berquist BR, Wilson DM 3rd, et al. Stoichiometry of base excision repair proteins correlates with increased somatic CAG instability in striatum over cerebellum in Huntington's disease transgenic mice. PLoS Genet [Internet]. 2009 [cited 2016 Jan 15];5:e1000749. Available from: http://dx.doi.org/10.1371/journal.pgen.1000749.
   PubMed Web of Science ®Google Scholar
• Lokanga RA, Senejani AG, Sweasy JB, et al. Heterozygosity for a hypomorphic Polβ mutation reduces the expansion frequency in a mouse model of the Fragile X-related disorders. PLoS Genet [Internet]. 2015 [cited 2016 Jan 15];11:e1005181. Available from: http://dx.doi.org/10.1371/journal.pgen.1005181.
   PubMed Web of Science ®Google Scholar
• Ehrnhoefer DE, Skotte NH, Ladha S, et al. p53 increases caspase-6 expression and activation in muscle tissue expressing mutant Huntingtin. Hum Mol Genet. 2014;23:717–729.
   PubMed Web of Science ®Google Scholar
• Martin LJ, Chen K, Liu Z. Adult motor neuron apoptosis is mediated by nitric oxide and Fas death receptor linked by DNA damage and p53 activation. J Neurosci. 2005;25:6449–6459.
   PubMed Web of Science ®Google Scholar
• Roe CM, Behrens MI, Xiong C, et al. Alzheimer disease and cancer. Neurology. 2005;64:895–898.
   PubMed Web of Science ®Google Scholar
• Roe CM, Fitzpatrick AL, Xiong C, et al. Cancer linked to Alzheimer disease but not vascular dementia. Neurology. 2010;74:106–112.
   PubMed Web of Science ®Google Scholar
• Tabarés-Seisdedos R, Dumont N, Baudot A, et al. No paradox, no progress: inverse cancer comorbidity in people with other complex diseases. Lancet Oncol. 2011;12:604–608.
   PubMed Web of Science ®Google Scholar
• Shi HB, Tang B, Liu YW, et al. Alzheimer disease and cancer risk: a meta-analysis. J Cancer Res Clin Oncol. 2015;141:485–494.
   PubMed Web of Science ®Google Scholar
• Catalá-López F, Suárez-Pinilla M, Suárez-Pinilla P, et al. Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies. Psychother Psychosom. 2014;83:89–105.
   PubMed Web of Science ®Google Scholar
• Driver JA. Inverse association between cancer and neurodegenerative disease: review of the epidemiologic and biological evidence. Biogerontology. 2014;15:547–557.
   PubMed Web of Science ®Google Scholar
• Chakarov S, Petkova R, Zhelev N, et al. DNA repair and carcinogenesis. In: Lane DP, editor. DNA repair and individual repair capacity. Dundee: Dundee Science Press; 2014. p. 471–518.
   Google Scholar
• Driver JA, Logroscino G, Buring JE, et al. A prospective cohort study of cancer incidence following the diagnosis of Parkinson's disease. Cancer Epidemiol Biomark Prev. 2007;16:1260–1265.
   PubMed Web of Science ®Google Scholar
• Inzelberg R, Jankovic J. Are Parkinson disease patients protected from some but not all cancers? Neurology. 2007;69:1542–1550.
   PubMed Web of Science ®Google Scholar
• Hasle H. Pattern of malignant disorders in individuals with Down's syndrome. Lancet Oncol. 2001;2:429–436.
   PubMed Web of Science ®Google Scholar
• Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Med. 1997;3:730–737.
   PubMed Web of Science ®Google Scholar
• Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003;100:3983–3988.
   PubMed Web of Science ®Google Scholar
• Schatton T, Murphy GF, Frank NY, et al. Identification of cells initiating human melanomas. Nature. 2008;451:345–349.
   PubMed Web of Science ®Google Scholar
• Petkova R, Chelenkova P, Georgieva E, et al. What's your poison? Impact of individual repair capacity on the outcomes of genotoxic therapies in cancer. Part II – information content and validity of biomarkers for individual repair capacity in the assessment of outcomes of anticancer therapy. Biotechnol Biotechnol Equip. 2014;28:2–7.
   PubMed Web of Science ®Google Scholar
• Agardh CD, Zhang H, Smith ML, et al. Free radical production and ischemic brain damage: influence of postischemic oxygen tension. Int J Dev Neurosci. 1991;9:127–138.
   PubMed Web of Science ®Google Scholar
• Chen H, Yoshioka H, Kim GS, et al. Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection. Antioxid Redox Signal. 2011;14:1505–1517.
   PubMed Web of Science ®Google Scholar
• Luo Y, Ji X, Ling F, et al. Impaired DNA repair via the base-excision repair pathway after focal ischemic brain injury: a protein phosphorylation-dependent mechanism reversed by hypothermic neuroprotection. Front Biosci. 2007;12:1852–1862.
   PubMed Web of Science ®Google Scholar
• Chelenkova P, Petkova R, Chamova T, et al. Homozygous carriership of the wildtype allele of the XPCins83 polymorphism is an independent protective factor against cerebrovascular incidents in the Bulgarian population. Compt Rend Acad Bulg Sci. 2014;67:263–268.
   Web of Science ®Google Scholar
• Ghosh S, Canugovi C, Yoon JS, et al. Partial loss of the DNA repair scaffolding protein, Xrcc1, results in increased brain damage and reduced recovery from ischemic stroke in mice. Neurobiol Aging. 2015;36:2319–2330.
   PubMed Web of Science ®Google Scholar
• Prelli F, Castaño E, Glenner GG, et al. Differences between vascular and plaque core amyloid in Alzheimer's disease. J Neurochem. 1988;51:648–651.
   PubMed Web of Science ®Google Scholar
• Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes. 1991;40:405–412.
   PubMed Web of Science ®Google Scholar
• Vartanian V, Lowell B, Minko IG, et al. The metabolic syndrome resulting from a knockout of the NEIL1 DNA glycosylase. Proc Natl Acad Sci USA. 2006;103:1864–1869.
   PubMed Web of Science ®Google Scholar
• Park MH, Kwak SH, Kim KJ, et al. Identification of a genetic locus on chromosome 4q34-35 for type 2 diabetes with overweight. Exp Mol Med [Internet]. 2013 [cited 2016 Jan 15];45:e7. Available from: http://dx.doi.org/10.1038/emm.2013.5.
   Google Scholar
• Chakarov S, Petkova R, Russev GCh. Individual capacity for detoxification of genotoxic compounds and repair of DNA damage. Commonly used methods for assessment of capacity for DNA repair. Biodiscovery [Internet]. 2014 [cited 2016 Jan 15];11:2. Available from: http://dx.doi.org/10.7750/BioDiscovery.2014.11.2.
   Google Scholar
• Petkova R, Chelenkova P, Georgieva E, et al. What's your poison? Impact of individual repair capacity on the outcomes of genotoxic therapies in cancer. Part I – role of individual repair capacity in the constitution of risk for late-onset multifactorial disease. Biotechnol Biotechnol Equip. 2013;27:4208–4216.
   Web of Science ®Google Scholar
• Sykora P, Misiak M, Wang Y, et al. DNA polymerase β deficiency leads to neurodegeneration and exacerbates Alzheimer disease phenotypes. Nucleic Acids Res. 2015;43:943–959.
   PubMed Web of Science ®Google Scholar
• Wilson DM 3rd, McNeill DR. Base excision repair and the central nervous system. Neuroscience. 2007;145:1187–1200.
   PubMed Web of Science ®Google Scholar
• Coppedè F, Mancuso M, Lo Gerfo A, et al. A Ser326Cys polymorphism in the DNA repair gene hOGG1 is not associated with sporadic Alzheimer's disease. Neurosci Lett. 2007;414:282–285.
   PubMed Web of Science ®Google Scholar
• Parildar-Karpuzoğlu H, Doğru-Abbasoğlu S, Hanagasi HA, et al. Single nucleotide polymorphisms in base-excision repair genes hOGG1, APE1 and XRCC1 do not alter risk of Alzheimer's disease. Neurosci Lett. 2008;442:287–291.
   PubMed Web of Science ®Google Scholar
• Gencer M, Dasdemir S, Cakmakoglu B, et al. DNA repair genes in Parkinson's disease. Genet Test Mol Biomark. 2012;16:504–507.
   PubMed Web of Science ®Google Scholar
• Kohno T, Shinmura K, Tosaka M, et al. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene. 1998;16:3219–3225.
   PubMed Web of Science ®Google Scholar
• Coppedè F, Mancuso M, Lo Gerfo A, et al. Association of the hOGG1 Ser326Cys polymorphism with sporadic amyotrophic lateral sclerosis. Neurosci Lett. 2007;420:163–168.
   PubMed Web of Science ®Google Scholar
• Coppedè F, Lo Gerfo A, Carlesi C, et al. Lack of association between the APEX1 Asp148Glu polymorphism and sporadic amyotrophic lateral sclerosis. Neurobiol Aging. 2010;31:353–355.
   PubMed Web of Science ®Google Scholar
• Zhang H, Xu Y, Zhang Z, et al. The hOGG1 Ser326Cys polymorphism and prostate cancer risk: a meta-analysis of 2584 cases and 3234 controls. BMC Cancer [Internet]. 2011 [cited 2016 Jan 15];11:391. Available from: http://dx.doi.org/10.1186/1471-2407-11-391.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang L, Song Z, et al. Genetic polymorphisms in DNA repair genes OGG1, APE1, XRCC1, and XPD and the risk of age-related cataract. Ophthalmology. 2012;119:900–906.
   PubMed Web of Science ®Google Scholar
• Jing B, Wang J, Chang WL, et al. Association of the polymorphism of APE1 gene with the risk of prostate cancer in Chinese Han population. Clin Lab. 2013;59:163–168.
   PubMed Web of Science ®Google Scholar
• Li Q, Huang L, Rong L, et al. hOGG1 Ser326Cys polymorphism and risk of childhood acute lymphoblastic leukemia in a Chinese population. Cancer Sci. 2011;102:1123–1127.
   PubMed Web of Science ®Google Scholar
• Thomas M, Kalita A, Labrecque S, et al. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Molec Cell Biol. 1999;19:1092–1100.
   PubMed Web of Science ®Google Scholar
• Chakarov S, Petkova R, Russev GCh. p53 – guardian angel and archangel. Biotechnol Biotechnol Eq. 2012;26:2695–2702.
   Web of Science ®Google Scholar
• Khalil HS, Chakarov S, Zhelev N. Ataxia-telangiectasia mutated (ATM). In: Lane DP, editor. ATM, a damage sensor and cancer target. Dundee: Dundee Science Press; 2014. p. 10–19.
   Google Scholar
• Ara S, Lee PSY, Hansen MF, et al. Codon 72 polymorphism of the TP53 gene. Nucleic Acids Res. 1990;18:4961.
   PubMed Web of Science ®Google Scholar
• Ibáñez K, Boullosa C, Tabarés-Seisdedos R, et al. Molecular evidence for the inverse comorbidity between central nervous system disorders and cancers detected by transcriptomic meta-analyses. PLoS Genet [Internet]. 2014 [cited 2016 Jan 15];10:e1004173. Available from: http://dx.doi.org/10.1371/journal.pone.0123864.
   PubMed Web of Science ®Google Scholar
• Rosenmann H, Meiner Z, Kahana E, et al. An association study of the codon 72 polymorphism in the pro-apoptotic gene p53 and Alzheimer's disease. Neurosci Lett. 2003;340:29–32.
   PubMed Web of Science ®Google Scholar
• Scacchi R, Gambina G, Moretto G, et al. Association study between P53 and P73 gene polymorphisms and the sporadic late-onset form of Alzheimer's disease. J Neural Transm. 2009;116:1179–1184.
   PubMed Web of Science ®Google Scholar
• Ørsted DD, Bojesen SE, Tybjaerg-Hansen A, et al. Tumor suppressor p53 Arg72Pro polymorphism and longevity, cancer survival, and risk of cancer in the general population. J Exp Med. 2007;204:1295–1301.
   PubMed Web of Science ®Google Scholar
• Bojesen SE, Nordestgaard BG. The common germline Arg72Pro polymorphism of p53 and increased longevity in humans. Cell Cycle. 2008;7:158–163.
   PubMed Web of Science ®Google Scholar